Susan G Anderson, MD
Internal Medicine · San Carlos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Anderson’s office at (650) 321-4121 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G74164 · Current
Licensed to practise in California · since 1992 · expires 2028-05-31 · Yale University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$2,571
Medicare paid this office $2,571 for 23 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 11 | $1,366 | $124 |
Who their Medicare patients are
23 Original Medicare patients in 2024. Average age 77 · Under 65 0% · Also on Medicaid 0% · Health risk score 0.77. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 52%.
The office billed $8,844, Medicare allowed $3,390 and paid $2,571; for 333 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 23 | 333 | 77 | 0.77 | $8,844 | $2,571 |
| 2023 | 135 | 712 | 78 | 0.97 | $57,948 | $16,775 |
| 2022 | 207 | 2,920 | 78 | 0.86 | $107,964 | $32,379 |
| 2021 | 208 | 3,663 | 78 | 0.87 | $101,253 | $30,559 |
| 2020 | 205 | 2,092 | 77 | 0.93 | $102,661 | $26,227 |
| 2019 | 324 | 2,018 | 77 | 1.03 | $172,593 | $48,399 |
| 2018 | 289 | 837 | 76 | 1.10 | $168,174 | $47,550 |
| 2017 | 300 | 1,401 | 78 | 1.02 | $146,120 | $42,267 |
| 2016 | 280 | 791 | 76 | 1.02 | $123,883 | $35,739 |
| 2015 | 264 | 1,149 | 76 | 0.95 | $122,383 | $39,450 |
| 2014 | 308 | 937 | 75 | 1.04 | $140,688 | $43,556 |
| 2013 | 273 | 2,600 | 76 | 1.13 | $125,840 | $35,719 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 60 | $6,966 | $114 |
| Long return visit (40+ min) | 23 | $3,272 | $142 |
| New patient visit (30+ min) | 26 | $2,289 | $88 |
| Short return visit (20+ min) | 16 | $1,284 | $80 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 12 | $603 | $50 |
| Automated urinalysis test | 12 | $26 | $2 |
2022: 9 services
| Return visit (30+ min) | 89 | $10,110 | $111 |
| Long return visit (40+ min) | 48 | $8,625 | $176 |
| Short return visit (20+ min) | 33 | $2,825 | $83 |
| New patient visit (30+ min) | 18 | $1,609 | $89 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 24 | $1,214 | $51 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 15 | $1,098 | $69 |
| Injection of drug or substance under skin or into muscle | 25 | $364 | $14 |
| Automated urinalysis test | 30 | $67 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 16 | $27 | None |
2021: 13 services
| Long return visit (40+ min) | 59 | $10,505 | $167 |
| Return visit (30+ min) | 77 | $8,977 | $114 |
| Short return visit (20+ min) | 30 | $2,334 | $78 |
| New patient visit (30+ min) | 12 | $1,096 | $91 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 24 | $998 | $31 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 12 | $955 | $80 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 15 | $770 | $51 |
| Injection of drug or substance into vein | 15 | $723 | $43 |
| Injection of drug or substance under skin or into muscle | 12 | $258 | $14 |
| Automated urinalysis test | 36 | $81 | $2 |
| Infusion, normal saline solution , 1000 cc | 13 | $28 | None |
| Injection, ceftriaxone sodium, per 250 mg | 12 | $28 | None |
| Injection, ketorolac tromethamine, per 15 mg | 12 | $10 | None |
2020: 9 services
| Long return visit (40+ min) | 80 | $10,318 | $123 |
| Return visit (30+ min) | 91 | $7,864 | $84 |
| Short return visit (20+ min) | 26 | $1,858 | $69 |
| Extended office or other outpatient service, first hour | 12 | $1,482 | $123 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 13 | $1,074 | $77 |
| Injection of drug or substance into vein | 18 | $832 | $42 |
| Injection of drug or substance under skin or into muscle | 11 | $186 | $14 |
| Automated urinalysis test | 26 | $63 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 23 | $60 | None |
2019: 11 services
| Long return visit (40+ min) | 125 | $16,561 | $125 |
| Return visit (30+ min) | 169 | $15,972 | $92 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 31 | $2,557 | $73 |
| Extended office or other outpatient service, first hour | 21 | $2,529 | $120 |
| Short return visit (20+ min) | 16 | $960 | $60 |
| Injection of drug or substance into vein | 22 | $900 | $41 |
| Injection of drug or substance under skin or into muscle | 18 | $368 | $17 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 17 | $275 | $16 |
| Automated urinalysis test | 45 | $117 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 39 | $103 | None |
| Infusion, normal saline solution , 1000 cc | 17 | $33 | None |
2018: 12 services
| Long return visit (40+ min) | 115 | $14,033 | $119 |
| Return visit (30+ min) | 133 | $12,526 | $89 |
| Extended office or other outpatient service, first hour | 29 | $3,425 | $118 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 33 | $2,838 | $75 |
| Injection of drug or substance into vein | 18 | $860 | $48 |
| Short return visit (20+ min) | 14 | $785 | $52 |
| Injection of drug or substance under skin or into muscle | 16 | $350 | $21 |
| Inhalation treatment for airway obstruction or sputum production | 13 | $280 | $20 |
| Automated urinalysis test | 39 | $119 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 41 | $106 | None |
| Infusion, normal saline solution , 1000 cc | 12 | $25 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 11 | $1 | None |
2017: 15 services
| Long return visit (40+ min) | 111 | $14,357 | $127 |
| Return visit (30+ min) | 131 | $12,402 | $90 |
| Extended office or other outpatient service, first hour | 34 | $3,986 | $117 |
| Short return visit (20+ min) | 37 | $2,335 | $60 |
| Injection of drug or substance into vein | 34 | $2,071 | $59 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 16 | $1,215 | $71 |
| Inhalation treatment for airway obstruction or sputum production | 16 | $312 | $20 |
| Injection of drug or substance under skin or into muscle | 11 | $284 | $26 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 15 | $187 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $179 | $16 |
| Automated urinalysis test | 47 | $157 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 32 | $81 | None |
| Infusion, normal saline solution , 1000 cc | 21 | $37 | None |
| Injection, ketorolac tromethamine, per 15 mg | 12 | $15 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 13 | $1 | None |
2016: 15 services
| Long return visit (40+ min) | 103 | $12,285 | $118 |
| Return visit (30+ min) | 95 | $8,315 | $87 |
| Extended office or other outpatient service, first hour | 37 | $3,434 | $90 |
| Short return visit (20+ min) | 33 | $1,856 | $56 |
| Injection of drug or substance into vein | 22 | $1,337 | $58 |
| Hepatitis b vaccine, adult dosage (3 dose schedule) | 17 | $1,257 | $60 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 12 | $854 | $71 |
| Administration of influenza virus vaccine | 20 | $608 | $30 |
| Administration of hepatitis b vaccine | 16 | $608 | $30 |
| Inhalation treatment for airway obstruction or sputum production | 13 | $252 | $18 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 14 | $250 | $18 |
| Automated urinalysis test | 25 | $78 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 23 | $54 | None |
| Infusion, normal saline solution , 1000 cc | 25 | $47 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 13 | $1 | None |
2015: 17 services
| Long return visit (40+ min) | 87 | $12,052 | $135 |
| Return visit (30+ min) | 68 | $6,560 | $96 |
| Short return visit (20+ min) | 35 | $2,579 | $64 |
| Extended office or other outpatient service, first hour | 25 | $2,464 | $95 |
| Injection of drug or substance into vein | 36 | $2,254 | $61 |
| Hepatitis b vaccine, adult dosage (3 dose schedule) | 19 | $1,580 | $59 |
| Administration of influenza virus vaccine | 31 | $972 | $31 |
| Administration of hepatitis b vaccine | 19 | $790 | $30 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 29 | $515 | $18 |
| Infusion into a vein for hydration, each additional hour | 13 | $258 | $14 |
| Inhalation treatment for airway obstruction or sputum production | 12 | $229 | $19 |
| Urinalysis, manual test | 35 | $123 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 18 | $47 | None |
| Automated urinalysis test | 12 | $41 | $3 |
| Infusion, normal saline solution , 1000 cc | 24 | $30 | None |
| Injection, ketorolac tromethamine, per 15 mg | 13 | $16 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 11 | $0 | None |
2014: 19 services
| Long return visit (40+ min) | 73 | $9,590 | $130 |
| Return visit (30+ min) | 74 | $6,960 | $90 |
| Short return visit (20+ min) | 60 | $4,014 | $63 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 41 | $3,084 | $70 |
| Extended office or other outpatient service, first hour | 29 | $2,608 | $90 |
| New patient visit (45+ min) | 13 | $1,858 | $143 |
| Hepatitis b vaccine, adult dosage (3 dose schedule) | 19 | $1,580 | $59 |
| Administration of influenza virus vaccine | 43 | $1,306 | $30 |
| New patient visit (30+ min) | 13 | $1,203 | $93 |
| Injection of drug or substance into vein | 14 | $857 | $57 |
| Administration of hepatitis b vaccine | 19 | $820 | $30 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 43 | $766 | $18 |
| Infusion into a vein for hydration, 31-60 minutes | 11 | $638 | $58 |
| New patient visit (15+ min) | 14 | $513 | $37 |
| Inhalation treatment for airway obstruction or sputum production | 15 | $285 | $19 |
| Urinalysis, manual test | 42 | $147 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 21 | $75 | None |
| Infusion, normal saline solution , 1000 cc | 34 | $37 | None |
| Injection, ketorolac tromethamine, per 15 mg | 12 | $9 | None |
2013: 15 services
| Return visit (30+ min) | 80 | $7,726 | $95 |
| Long return visit (40+ min) | 51 | $6,265 | $118 |
| Short return visit (20+ min) | 72 | $4,906 | $62 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 29 | $2,406 | $78 |
| Injection of drug or substance into vein | 38 | $2,274 | $57 |
| New patient visit (45+ min) | 15 | $2,141 | $143 |
| Extended office or other outpatient service, first hour | 23 | $2,015 | $88 |
| New patient visit (30+ min) | 23 | $1,764 | $77 |
| New patient visit (15+ min) | 28 | $1,639 | $59 |
| Injection of additional new drug or substance into vein | 12 | $272 | $23 |
| Infusion into a vein for hydration, each additional hour | 14 | $213 | $15 |
| Urinalysis, manual test | 48 | $183 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 38 | $181 | None |
| Infusion, normal saline solution , 1000 cc | 20 | $20 | None |
| Injection, ketorolac tromethamine, per 15 mg | 11 | $10 | None |
Money from drug and device companies
$23 in 2023
A payment is not proof that care is biased.
| Bavarian Nordic A/S | Jynneos | $23 | 1 payment
|
See the published payment
| Bavarian Nordic A/S | Meals · 2023-05-24 | Jynneos | $23 |
Professional record
- NPI
- 1104985621
- Licence
- CA G74164California G74164: Current · expires 2028-05-31
- Trained
- Yale University School of Medicine, 1990
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-12-08
- NPI last updated
- 2020-03-04
- NPI record certified
- 2020-03-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 211 Quarry Rd Ste 102, Palo Alto, CA, 94304